Clifford Chance

Clifford Chance advises HH&L Acquisition on its US$414 million IPO and NYSE listing

Leading international law firm Clifford Chance has advised HH&L Acquisition Co., a special purpose acquisition company (SPAC), on its formation, US$414 million IPO and listing on the New York Stock Exchange. The SPAC targets the healthcare sector and is one of the largest SPAC IPOs by Asian sponsors.

Partners Ying White and Fang Liu co-led on the deal, supported by senior associate Yuling Geng and associates Hazel He and Bernice Lin in Asia Pacific. In New York, partners Andrew Epstein and Jeffrey LeMaster assisted.

Ying noted, "Our cross-border team has been very excited to assist HH&L throughout its formation to listing. This is a strategically significant transaction as it is focused on the burgeoning healthcare sector in Asia, in particular Greater China."

Fang Liu added, "SPAC has become an increasingly popular avenue for both businesses to go public and private equity firms to seek AUM or exit of their portfolios. The seamless coordination among our practices in funds, US capital markets and M&As as well as across our offices in the Asia and US regions provides clients with a strong support in getting such deals done."